Dendritic Cells in the Regulation of Immunity and Inflammation

A special issue of Vaccines (ISSN 2076-393X).

Deadline for manuscript submissions: closed (28 February 2022) | Viewed by 467

Special Issue Editor

Universitätsklinik Erlangen und Medizinische Fakultät, Erlangen, Germany
Interests: cancer; vaccine; DC; antigen targeting; antigen-targeting antibodies; clr; dcir; dec205; dendritic cell subsets; moDC

Special Issue Information

Dear Colleagues,

Dendritic cells (DCs) are truly major players in the immune system, particularly in adaptive immunity. In healthy individuals, DCs are drivers and fine-tuners of T-cell responses directed against invading pathogens or cancer cells. In parallel, DCs control autoreactive T cells, thereby maintaining T-cell tolerance. Under various disease conditions, a disruption of this delicate balance can lead to chronic infections, tumor evasion, or autoimmunity. 

This Special Issue focuses on dendritic cells in the regulation of immune-mediated diseases. Submissions of original articles, systematic reviews, short communications, and other types of article on related topics are welcome. Manuscripts will follow standard journal peer-review practices, and those accepted for publication will appear in the Special Issue on Dendritic Cells in the Regulation of Immunity and Inflammation. We look forward to receiving your contributions.

Prof. Dr. Diana Dudziak
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.


  • dendritic cells
  • DC
  • T cells
  • cancer
  • immune-mediated diseases
  • inflammation
  • adaptive immunity

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop